Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux® [Phase 3]
Phase 3 clinical trial evaluating OTD70DERM for radiodermatitis caused by radiotherapy in head and neck cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: Improving End of Life Care in Head and Neck Cancer
A Memorial Sloan Kettering trial evaluating end-of-life care for head and neck squamous cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 3]
Phase 3 clinical trial update evaluating treatment for locally advanced head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This Phase 2 study evaluated the Akt inhibitor MK-2206 in patients with recurrent or metastatic nasopharyngeal squamous cell carcinoma. The …
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Ponatinib for Squamous Cell Lung and Head and Neck Cancers [Phase 2, Phase 3]
Ponatinib was studied in Phase 2/Phase 3 trials for squamous cell carcinoma of the lung and head and neck squamous cell carcinoma. The studi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Study of Sorafenib/Cetuximab in Head and Neck Cancer [Phase 1, Phase 2]
This document summarizes the completion of a Phase 1/2 clinical trial evaluating sorafenib in combination with cetuximab for head and neck s…
-
CLINICAL_TRIALS research · 2014-12-03Clinical Trial Update: Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma [NA]
Clinical trial update investigating circulating tumor cells as an early predictive biomarker for head and neck squamous cell carcinoma; no t…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Cetuximab and Lenalidomide in Head and Neck [Phase 2]
Phase 2 trial update of cetuximab plus lenalidomide in head and neck squamous cell carcinoma. The study completed enrollment and results wer…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Efficacy Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Platinum-Refractory Head and Neck Cancers [Phase 3]
This is a Phase 3 trial evaluating REOLYSIN in combination with paclitaxel and carboplatin for platinum-refractory head and neck squamous ce…
-
CLINICAL_TRIALS trial_result · 2014-11-04Clinical Trial Update: Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma [Phase 2]
Phase 2 study of REOLYSIN in combination with paclitaxel and carboplatin for head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer [NA]
This Georgetown University-sponsored trial evaluated pharmacogenetic-guided selection between cetuximab (Erbitux) and cisplatin for head and…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial of PF-00299804 in patients with metastatic or recurrent head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Treatment of Advanced Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial for advanced head and neck squamous cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer [Phase 3]
Phase 3 trial results for Palifermin to reduce oral mucositis in patients with locally advanced head and neck cancer. The results were poste…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy [Phase 2]
Phase 2 trial evaluating whether selenomethionine reduces mucositis in locally advanced head and neck cancer treated with cisplatin and radi…
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma [Phase 3]
Phase 3 trial evaluating sentinel lymph node assessment in head and neck squamous cell carcinoma was terminated; results were posted in 2014…
-
CLINICAL_TRIALS withdrawal · 2014-07-02Clinical Trial Update: A Post-marketing Surveillance Study on Erbitux in Combination With Platinum-based Chemotherapy in Metastatic/Recurrent Squamous Cell Cancer of the Head and Neck
A post-marketing surveillance trial of cetuximab (Erbitux) plus platinum-based chemotherapy for metastatic or recurrent head and neck squamo…
-
CLINICAL_TRIALS trial_result · 2014-06-20Clinical Trial Update: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]
This report notes the completion of a Phase 2 trial evaluating the combination of radiation therapy with chemotherapy for stage III or stage…
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating Erlotinib and Cetuximab with or without Bevacizumab in patients with metastatic or unresectable k…
-
CLINICAL_TRIALS research · 2014-06-10Clinical Trial Update: Intensive Nutrition Counselling in Patients With Head and Neck Cancer [NA]
This document provides an update on a clinical trial evaluating intensive nutrition counseling for patients with head and neck squamous cell…
-
CLINICAL_TRIALS research · 2014-06-06Clinical Trial Update: Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [Phase 1]
This Phase 1 clinical trial update examines a combination regimen of Erlotinib, Docetaxel, and radiation therapy for locally advanced head a…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase II trial of Nimotuzumab in combination with TPF chemotherapy for head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial comparing radiotherapy plus panitumumab versus chemoradiotherapy in unresected, locally advanced head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer [Phase 2]
This update presents results from a Phase 2 study of recurrent or metastatic squamous cell head and neck cancer sponsored by Eli Lilly; resu…
-
FDA approval · 2014-05-15FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Docetaxel (Sanofi-Aventis U.S. LLC), indicating an approved modification to its labeling and…